Expression and identification of human anti-idiotypic single chain antibody of nasopharyngeal carcinoma in E.coli

WANG Jing,LI Guan-cheng,TONG Yong-qing,ZHANG Zhi-jie

DOI: https://doi.org/10.3969/j.issn.1005-8982.2008.08.016

2008-01-01

Abstract:Objective To construct a new recombinant expression vector of nasopharyngeal carcinoma anti-idiotypic single chain antibody,and identify the product for the possible clinical use in active immunity therapy of nasopharyngeal carcinoma. Methods The G22 gene was emplified by PCR and digest by restrictive enzyme before cloned into pET25b(+). It was then transformed into E.Coli DH5αand the positive recombinant plasmid named pET25b(+)-G22 was sequenced. The target protein was expressed after transformed into E.Coli BL21(DE3),and induced with IPTG. The cell extracts were purified by His-tag fusion protein purification kit under denaturing condition. Western blot analysis was performed after solubility analysis. Results The sequence of target gene in recombinant plasmid pET25b(+)-G22 was the same as G22 and could be efficiently expressed in E.coli. Protein production mainly was the inclusion body,but could be purified by His-tag fusion protein purification kit. The western blot analysis was proved that the protein had immunologic specificity and bioactivity. Conclusion The Ab2βScFv G22 is successfully cloned and expressed in this study. The purified product has biological activity. These results pave the way for further studies.